DexCom, Inc. (NASDAQ:DXCM – Get Rating) hit a new 52-week high on Thursday following a stronger than expected earnings report. The stock traded as high as $126.44 and last traded at $121.69, with a volume of 325550 shares changing hands. The stock had previously closed at $124.93. The medical device company reported $0.17 earnings per […]
Westpac Banking Corp lifted its holdings in DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 64.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 52,231 shares of the medical device company’s stock after purchasing an additional 20,459 shares during the quarter. Westpac Banking Corp’s […]
Axonics (NASDAQ:AXNX – Get Rating) and DexCom (NASDAQ:DXCM – Get Rating) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends. Risk and Volatility Axonics has a beta of 0.39, suggesting that its […]
DexCom, Inc. (NASDAQ:DXCM – Get Rating) Director Steven Robert Pacelli sold 5,031 shares of the company’s stock in a transaction dated Thursday, April 27th. The stock was sold at an average price of $126.00, for a total value of $633,906.00. Following the transaction, the director now directly owns 132,686 shares of the company’s stock, valued […]